4
Changes in Ownership
Benitec Biopharma Inc. Filed Acc 0001012975-25-000812
Options or other derivatives
- Chief Executive Officer acquired 450,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Banks Jerel A. · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-11-18 | Grant or award : show line 1 in the form Options (right to buy) | +450,000 | 450,000 | D |
Loading xslF345X05/form4.xml…